Rapid responses are electronic letters to the editor. They enable our users to debate issues raised in articles published on thebmj.com. Although a selection of rapid responses will be included online and in print as readers' letters, their first appearance online means that they are published articles. If you need the url (web address) of an individual response, perhaps for citation purposes, simply click on the response headline and copy the url from the browser window. Letters are indexed in PubMed.
It's striking that the UK has half the incidence of end-stage renal disease than the US. I'm also impressed that the majority of the UK's ESRD patients are transplanted which I agree is the best treatment for ESRD. Prevention, of course, would be even better. What the article failed to reference is that 90% of dialysis has been preventable since 2002 (1). If that were known (2), there would be no waiting list at all for a cadaver kidney transplant in either the UK or the US. There would be no need for living donors, and both countries could be dialysis-free within 5 years.
In acute renal therapy, it's also possible to avoid renal replacement therapy (RRT) (3).
1. Paper #1 at www.genomed.com/publications (abstract at PubMed ID: 12396747)
2. Paper #9 at www.genomed.com/publications
I am the Founder, CEO, and majority shareholder of GenoMed, Inc, a NextGen Disease Management company that uses genomics to solve diseases. We use knowledge of disease-causing genes to improve prediction and treatment of common diseases like kidney failure. We repurpose already existing drugs whenever possible.